Literature DB >> 3840344

Reactions of lipoamide dehydrogenase and glutathione reductase with arsonic acids and arsonous acids.

F C Knowles.   

Abstract

Lipoamide dehydrogenase reacts irreversibly with arsonous acids, RAs(OH)2, and arsonic acids, RAs(O)(OH)2, to form enzyme-inhibitor complexes. The formation of inactive enzyme requires NADH and is kinetically first order in the presence of excess arsonous acid. The second-order rate constant for formation of the enzyme-inhibitor complex was 545 min-1 M-1 for phenylarsonous acid, C6H5As(OH)2, and 5640 min-1 M-1 for methanearsonous acid, CH3As(OH)2. The kinetics of formation of inactive enzyme in the presence of arsonic acids was found to obey a rate law predicted by a two-step mechanism in which a rate-limiting reduction of an arsonic acid to the corresponding arsonous acid by reduced enzyme, E(SH)2, preceded formation of an inactive binary complex of reduced enzyme and arsonous acid: ES2 + NADH + H+ = E(SH)2 + NAD+; E(SH)2 + RAs(O)(OH)2 = ES2 + RAs(OH)2 + H2O; and E(SH)2 + RAs(OH)2 = ES2AsR + 2H2O. GSSG reductase reacts reversibly with C6H5As(OH)2 to form an inactive binary addition compound in the presence of NADPH. The value of the association constant for formation of enzyme inhibitor complex at pH 7.0 was 119 M-1. The initial rate of the GSSG reductase-catalyzed oxidation of NADPH by GSSG was insensitive to MeAs(OH)2. The kinetics of inhibition of GSSG reductase by arsenite and C6H5As(O)(OH)2 were found to obey the rate law described for lipoamide dehydrogenase and arsonic acids. GSSG reductase catalyzed the oxidation of NADPH by p-arsanilic acid. The initial rate of oxidation of NADPH was linearly dependent on enzyme concentration. The turnover number for GSSG reductase with p-arsanilic acid as an oxidant was 0.13 mol NADPH mol FAD-1 min-1.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3840344     DOI: 10.1016/0003-9861(85)90472-2

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  11 in total

1.  Cell-free mercury volatilization activity from three marine caulobacter strains.

Authors:  G Y Ji; S P Salzberg; S Silver
Journal:  Appl Environ Microbiol       Date:  1989-02       Impact factor: 4.792

2.  Purification of NADPH-dependent electron-transferring flavoproteins and N-terminal protein sequence data of dihydrolipoamide dehydrogenases from anaerobic, glycine-utilizing bacteria.

Authors:  D Dietrichs; M Meyer; B Schmidt; J R Andreesen
Journal:  J Bacteriol       Date:  1990-04       Impact factor: 3.490

3.  Inhibition by methylated organo-arsenicals of the respiratory 2-oxo-acid dehydrogenases.

Authors:  Erik R Bergquist; Robert J Fischer; Kent D Sugden; Brooke D Martin
Journal:  J Organomet Chem       Date:  2009-03-15       Impact factor: 2.369

4.  Pyruvate: ferredoxin oxidoreductase from the sulfate-reducing Archaeoglobus fulgidus: molecular composition, catalytic properties, and sequence alignments.

Authors:  J Kunow; D Linder; R K Thauer
Journal:  Arch Microbiol       Date:  1995-01       Impact factor: 2.552

5.  Purification and comparative studies of dihydrolipoamide dehydrogenases from the anaerobic, glycine-utilizing bacteria Peptostreptococcus glycinophilus, Clostridium cylindrosporum, and Clostridium sporogenes.

Authors:  D Dietrichs; J R Andreesen
Journal:  J Bacteriol       Date:  1990-01       Impact factor: 3.490

6.  Nitrosative stress treatment of E. coli targets distinct set of thiol-containing proteins.

Authors:  Nicolas Brandes; Andrea Rinck; Lars Ingo Leichert; Ursula Jakob
Journal:  Mol Microbiol       Date:  2007-10-05       Impact factor: 3.501

7.  Arsenic(III) species inhibit oxidative protein folding in vitro.

Authors:  Danny Ramadan; Pumtiwitt C Rancy; Radhika P Nagarkar; Joel P Schneider; Colin Thorpe
Journal:  Biochemistry       Date:  2009-01-20       Impact factor: 3.162

Review 8.  Arsenic binding to proteins.

Authors:  Shengwen Shen; Xing-Fang Li; William R Cullen; Michael Weinfeld; X Chris Le
Journal:  Chem Rev       Date:  2013-06-28       Impact factor: 60.622

9.  Multivalency in the inhibition of oxidative protein folding by arsenic(III) species.

Authors:  Aparna Sapra; Danny Ramadan; Colin Thorpe
Journal:  Biochemistry       Date:  2014-12-30       Impact factor: 3.162

10.  Arsenic-based antineoplastic drugs and their mechanisms of action.

Authors:  Stephen John Ralph
Journal:  Met Based Drugs       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.